Patients with structural heart disease are at risk for life-threatening ventricular tachycardias (VTs). Implantable cardioverter-defibrillators (ICDs) can terminate VT, but often at the cost of traumatic shocks, syncope, or even exacerbation of underlying heart disease. Catheter ablation for VT can reduce the need for ICD therapies and is an increasingly important adjunct to the treatment of these patients.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Kuck, K.-H. et al. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomized controlled trial. Lancet 375, 31–40 (2010).
Epstein, A. E. et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 117, e350–e408 (2008).
Zipes, D. P. et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Circulation 114, e385–e484 (2006).
Aliot, E. M. et al. EHRA/HRS expert consensus on catheter ablation of ventricular arrhythmias. Heart Rhythm 6, 886–933 (2009).
Schron, E. B. et al. Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation 105, 589–594 (2002).
Moss, A. J. et al. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation 110, 3760–3765 (2004).
Poole, J. E. et al. Prognostic importance of defibrillator shocks in patients with heart failure. N. Engl. J. Med. 359, 1009–1017 (2008).
Cevik, C., Perez-Verdia, A. & Nugent, K. Implantable cardioverter defibrillators and their role in heart failure progression. Europace 11, 710–715 (2009).
Reddy, V. Y. et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N. Engl. J. Med. 357, 2657–2665 (2007).
Stevenson, W. G. et al. Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the multicenter thermocool ventricular tachycardia ablation trial. Circulation 118, 2773–2782 (2008).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
U. B. Tedrow has received research support from Biosense Webster and St. Jude Medical and has also acted as a consultant for St. Jude Medical. W. G. Stevenson declares no competing interests.
Rights and permissions
About this article
Cite this article
Tedrow, U., Stevenson, W. Catheter ablation for prevention of ventricular tachycardia. Nat Rev Cardiol 7, 181–182 (2010). https://doi.org/10.1038/nrcardio.2010.17
Issue Date:
DOI: https://doi.org/10.1038/nrcardio.2010.17
